A drug used to treat insomnia has protected mice against the buildup of the tau protein found to clump abnormally in ...

Q. We’ve been hearing lately about using ketamine, a thought that scares me to death. Here’s my story: I was on a gurney ...

The efficacy of an 'as-needed' zolpidem treatment schedule (up to 5 doses/week with intake nights chosen by the patient) in primary-care settings for patients with chronic insomnia has been ...

A. Regular reliance on zolpidem to get to sleep may increase a person’s risk for developing dementia or Alzheimer’s disease ...

The primary criteria were zolpidem consumption, defined as the number of doses/week, and its evolution during the study, defined as the difference between doses for weeks 1 and 3; intake was ...

Objective and Design: This open, non-comparative, multicentre study was designed to evaluate zolpidem consumption and evolution of its use for the treatment of insomnia on an 'as-needed' basis ...

Drugs, alcohol, cigarettes and weapons worth €688,200 have been seized by Revenue officers in a series of raids across the ...

Five more suspects have been arrested in connection with an alleged drug trafficking network headed by Pol Col Dr Anchulee ...

Weapons, drugs, alcohol and cigarettes have been seized by Revenue in multiple search operations across Ireland. Detector ...

A recent study published in Nature Neuroscience provides evidence that lemborexant, a medication used to treat insomnia, can reduce brain damage linked to Alzheimer’s disease in a mouse model. The ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...